Cargando…
Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway
Lung cancer remains the leading cause of cancer mortality because of its metastatic potential and high malignancy. The discovery of new applications for old drugs is a shortcut for cancer therapy. We recently investigated the antitumor effect of digoxin, a well-established drug for treating heart fa...
Autores principales: | Wang, Yingying, Hou, Yongqiang, Hou, Lanjiao, Wang, Wei, Li, Ke, Zhang, Zhe, Du, Bo, Kong, Dexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495431/ https://www.ncbi.nlm.nih.gov/pubmed/34549269 http://dx.doi.org/10.1042/BSR20211056 |
Ejemplares similares
-
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
por: Wang, Yingying, et al.
Publicado: (2020) -
DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
por: Wang, Zhengming, et al.
Publicado: (2018) -
Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
por: Wang, Zhengming, et al.
Publicado: (2020) -
Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog
por: Ye, Ting, et al.
Publicado: (2019) -
Disparate outcomes in nonsmall cell lung cancer by immigration status
por: Chau, Brittney, et al.
Publicado: (2021)